GBA Presents: RADIO SAVANT-!

Discussion in 'Stocks' started by stonedinvestor, May 13, 2022.

  1. vanzandt

    vanzandt

    CNC machining and injection molding are soooo 20th century.
    Moribund growth in 3D printing.
    Hardly a 3D play Stoney.
    The savant apologizes for not looking at it earlier and informing you of this (and whoever wrote it up at SA).

    It looks like revenues were light, or expected.
    A little beat on the top line.
    >>> Dead money.



    upload_2022-8-5_6-21-2.jpeg

    PE of 35 and 2.7X sales with no growth?!
    Down she goes....

    Bid is $39. I'll buy some there.
     
    Last edited: Aug 5, 2022
    #4961     Aug 5, 2022
  2. vanzandt

    vanzandt

    What kind of old school dinosaur, toxin producing, energy consuming, company have you given the children here Stoney?! I doubt they have solar panels on the roof up there in Minnesota. The snow will block the sun 8 months out of the year, and the other 4 months clouds of mosquitos do the trick.

    The readers deserve better.
    Get with the times.
    The children of today like winners like VZ's ABNB.

    upload_2022-8-5_6-51-48.jpeg
     
    #4962     Aug 5, 2022
  3. vanzandt

    vanzandt

    YIKES!!!!

    upload_2022-8-5_7-6-32.jpeg

    THE CHILDREN WANT COMPANIES THAT CLEAN THE ENVIRONMENT STONEY(!), NOT PUMP FORMALDEHYDE INTO THE AIR THEY BREATH.
     
    #4963     Aug 5, 2022
  4. Bluebird Bio reports Q2 EPS ($1.36), consensus ($1.24) 16:54 BLUE Reports Q2 revenue $1.519M, consensus $680,000. "The second quarter marked significant progress for bluebird bio and a precedent-setting moment for the field of gene therapy," said Andrew Obenshain, chief executive officer, bluebird bio. "With the FDA advisory committee's unanimous support for beti-cel and eli-cel for their target indications, we are now laser-focused on commercial readiness, and if approved, we anticipate launching both therapies in the fourth quarter of this year. Additionally, this quarter we advanced the remaining CMC steps ahead of our lovo-cel BLA submission, and we remain on track to submit the BLA in the first quarter of next year."
     
    #4964     Aug 5, 2022
  5. Protolabs reports Q2 non-GAAP EPS 46c, consensus 38c -

    [​IMG]
    Fri, August 5, 2022, 6:00 AM





    Record Revenue of $126.9 million in the Second Quarter of 2022;

    GAAP Earnings Per Share of $0.09, Non-GAAP Earnings Per Share of $0.46

    MAPLE PLAIN, Minn., August 05, 2022--(BUSINESS WIRE)--Proto Labs, Inc. ("Protolabs" or "the company") (NYSE: PRLB), the world’s leading provider of digital manufacturing services, today announced financial results for the second quarter ended June 30, 2022.

    Second Quarter 2022 Highlights include:

    • Revenue for the second quarter of 2022 was $126.9 million, representing a 3.1 percent increase compared to revenue of $123.0 million in the second quarter of 2021.

    • Hubs generated $11.3 million of revenue in the second quarter, representing year-over-year growth of 26.3 percent.

    • On a GAAP basis, costs related to the closure of Japan operations were $5.2 million in the quarter. These costs have been excluded from our Non-GAAP results. See "Non-GAAP Financial Measures" below.

    • Net income was $2.6 million, or $0.09 per diluted share.

    • Non-GAAP net income was $12.8 million, or $0.46 per diluted share.

    "Protolabs performed well in the quarter amid continuing supply chain challenges in the broader manufacturing industry and macroeconomic growth concerns," said Rob Bodor, President and Chief Executive Officer. "We continue to make progress on our 2022 strategic priorities and are focused to execute on the integration of Protolabs and Hubs, bringing together two leading digital manufacturing offers to create the most comprehensive digital manufacturing offer to serve our customers."

    Additional Second Quarter 2022 Highlights include:

    • Protolabs served 24,058 unique product developers during the second quarter of 2022.

    • Gross margin was 45.2 percent of revenue, compared to 44.9 percent of revenue in the first quarter of 2022.

    • Non-GAAP gross margin was 45.9 percent of revenue, compared to 45.7 percent of revenue in the first quarter of 2022.

    • EBITDA was $15.1 million, or 11.9 percent of revenue.

    • Adjusted EBITDA was $24.6 million, or 19.4 percent of revenue.

    • Cash and investments balance was $110.1 million as of June 30, 2022.
    "We are pleased with the sequential improvements in our margins in the second quarter," said Dan Schumacher, Chief Financial Officer. "We continue to focus on executing our strategy through disciplined investments and cost controls while delivering value to our customers and profitable growth to our shareholders."
     
    #4965     Aug 5, 2022
  6. vanzandt

    vanzandt

    WE ALREADY COVERED THAT... BUT HERE...

    AND HE MOCKED THE SAVANT!!!!


    LESL MISSES BAD... NEW ALL-TIME LOW WHILE THE MARKET FLIRTS WITH 4200
     
    #4966     Aug 5, 2022
  7. I figured out ROKU just in time to score a hugegain with it wil somene explain to me thgis guy-- FUBU?

    Q- what is FUBU?
    Q-Does anyone use the Fubu?


    FuboTV (NYSE:FUBO) shares surged more than 13% in after-hours trading Tuesday as the streaming TV platform provider forecast strong third-quarter subscriber growth and said it would conduct a "strategic review" of its online sports wagering platform.

    After U.S. markets closed, Fubo (FUBO) said that for its third quarter, it expects to have 1.475M to 1.515M subscribers worldwide, up from the 1.294M subscribers it reported for its recently completed second quarter. Of those anticipated subscriber figures, Fubo (FUBO) estimates that between 1.135M and 1.155M will be in North America, with the remainder in the rest of the world.

    Fubo (FUBO) also said it expects North America third-quarter revenue to be in a range of $200M to $205M, or potentially 31% more than the $156.7M Fubo (FUBO) in the third quarter of 2021.

    The company also announced a major change to its online sports wagering business plans that include seeking out a partner to build out the betting side of its business.

    In a statement, Fubo (FUBO) said that it believes in the opportunities of an integrated wagering platform that offers both live video and a sportsbook, but that it won't go about making such a feature available by itself.

    "We will no longer pursue this opportunity on our own," Fubo (FUBO) said. "We are in internal and external discussions to determine the best path forward."

    Along with its outlook, Fubo (FUBO) reported a second-quarter loss, excluding one-time items, of 45 cents a share, on revenue of $221.9M. Wall Street analysts had forecast Fubo (FUBO) to lose 57 cents a share on $226.6M in revenue for the quarter that ended in June.

    For its full year, Fubo (FUBO) forecast total revenue in a range of $930M to $955M, and estimates it will end the year with 1.67M and 1.71M subscribers.

    Fubo (FUBO) also disclosed its plans for its sports wagering business less than two months after launching pick 'em games for its online sportsbook.
     
    #4967     Aug 5, 2022
  8. vanzandt

    vanzandt


    LEVI > $19
    LESL> $12

    THE READERS TOOK NOTE AND VZ SAVED THEM HUGE $'S


    #1 FOR A REASON
     
    #4968     Aug 5, 2022
  9. vanzandt

    vanzandt

    I love it when Stoney ignores me lol.... it's lonely at the top; all savants know this of course. :p

    :cool::cool::cool::cool::cool::cool::cool::cool::cool::cool:
    :cool:savant for a reason:cool:
    :cool::cool::cool::cool::cool::cool::cool::cool::cool::cool:
     
    #4969     Aug 5, 2022
  10. Good Morning From Ct. // Trying to put together the new portfolio. So far we have secured the following names.


    -THE MURDER THE MARKET PORTFOLIO-


    A-?

    B- Helix Energy-$3.25

    C- Shel Oil-$52.25

    D- Olli bargain-$59

    E- Stratasys-$20


    F-Bluebird Bio-$4.50


    G- Siga -$19.15

    H- Double Verify-$25
     
    #4970     Aug 5, 2022